Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | PFE | TMO |
|---|
| Close | 27.46 | 648.43 |
| Market Cap | $157B | $240B |
| 1M | +2.20% | +10.75% |
| P/E (TTM) | 36.2 | 34.4 |
| Forward P/E | 8.6 | 21.8 |
| P/E 5-Yr Percentile | 88 | 65 |
| P/S | 2.5 | 5.2 |
| P/B | 1.8 | 4.6 |
| Dividend Yield | 5.38% | 0.29% |
| Latest Quarter Revenue | $15.0B | $12.0B |
| Revenue YoY | +2.6% | +10.5% |
| Gross Margin | 72.8% | — |
| Latest Quarter EPS | -0.04 | 4.68 |
| Avg Post-Earnings Move | ±2.2% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 2.36% |
| 90-Day Net Insider Buying | +$2.9M | −$38.9M |
PFE · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
